Search
Searching with a thematic focus on Health systems
Showing 1871-1880 of 2322 results
Pages
- Document
Pushing the boundaries: health and the next round of PRSPs
Working Group on Health and Development Issues, 2004This WEMOS report attempts to assess whether health has benefited from the Poverty Reduction Strategy Paper (PRSP) process launched in 1999 by the international community.DocumentHuman resources and health outcomes
Global Health Trust, 2003This Joint Learning Initiative working paper examines the relationship between health outcomes and human resources for health (HRH). By taking into account the main social and economic determinants for health, the authors develop a more reliable and comprehensive dataset on human resources for health.DocumentGoing from bad to worse: Malawi’s maternal mortality
Health Systems Trust, South Africa, 2004This paper, from the Health Systems Trust, is an analysis of the clinical, health systems and underlying reasons for the drastic deterioration in maternal health in Malawi.DocumentThe free trade agreement between Australia and the United States
British Medical Journal, 2004This article, published in the British Medical Journal, examines the recently signed bilateral trade agreement between Australia and the United States (US) and explores the implications of the agreement for drug regulation, subsidy and supply.DocumentManaging public expenditure for development results and poverty reduction
Overseas Development Institute, 2003This ODI working paper is a survey of the practice of results-oriented – or performance-based – public expenditure management in low income developing countries.DocumentImpact of public-private partnerships addressing access to pharmaceuticals in selected low and middle income countries: a synthesis report from studies in Botswana, Sri Lanka, Uganda and Zambia
Initiative on Public-Private Partnerships for Health, 2004This research report outlines how public-private partnerships (PPPs) intended to provide HIV drugs in three African countries are having limited impact because of the way in which these drugs are priced and patented.The report examines evidence on the effectiveness of two different types of PPPs: those set up to provide treatments for tropical diseases (in Sri Lanka, Uganda and Zambia), and thoDocumentImplementation of the WTO General Council Decision on Paragraph 6 of the DOHA Declaration on the Trips Agreement and Public Health
World Health Organization, 2004This report from the World Health Organization (WHO) explains the compulsory licensing system through which developing countries can acquire cheap generic medicines to protect public health without breaking international trade laws.This system was established by the World Trade Organisation (WTO) in 2003, in compliance with the 2001 Doha Declaration on the TRIPS (Trade-Related Aspects of IntellDocumentThe impact of implementation of ICH guidelines in non-ICH countries: Report of a WHO Meeting, Geneva, 13-15 September 2001
World Health Organization, 2002This World Health Organization (WHO) report considers issues arising in relation to the International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH). It sets out the benefits of the ICH process, as well as concerns about attempts to extend this process to non-ICH countries.DocumentMarketing authorization of pharmaceutical products with special reference to multisource (generic) products: A manual for drug regulatory authorities
World Health Organization, 1994This World Health Organization (WHO) manual provides detailed guidance for drug regulatory authorities (DRAs) on pre-market evaluation and marketing authorisation (drug registration).DocumentWHO-PAHO: guidelines for the use of foreign field hospitals in the aftermath of sudden-impact disasters
World Health Organization, 2003In complex disasters, field hospitals (civilian or military) have been used with notable success. However, the experience in the aftermath of natural disasters in developing countries has proven to be less satisfactory in terms of effectiveness and cost.Pages
